312 related articles for article (PubMed ID: 30879885)
21. Role of miR-1 expression in clear cell renal cell carcinoma (ccRCC): A bioinformatics study based on GEO, ArrayExpress microarrays and TCGA database.
Yan HB; Huang JC; Chen YR; Yao JN; Cen WN; Li JY; Jiang YF; Chen G; Li SH
Pathol Res Pract; 2018 Feb; 214(2):195-206. PubMed ID: 29258768
[TBL] [Abstract][Full Text] [Related]
22. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
Zhang Z; Pan B; Lv S; Ji Z; Wu Q; Lang R; He Q; Zhao X
Cell Physiol Biochem; 2018; 49(2):678-695. PubMed ID: 30165365
[TBL] [Abstract][Full Text] [Related]
23. Clinical Value of miR-101-3p and Biological Analysis of its Prospective Targets in Breast Cancer: A Study Based on The Cancer Genome Atlas (TCGA) and Bioinformatics.
Li CY; Xiong DD; Huang CQ; He RQ; Liang HW; Pan DH; Wang HL; Wang YW; Zhu HW; Chen G
Med Sci Monit; 2017 Apr; 23():1857-1871. PubMed ID: 28416776
[TBL] [Abstract][Full Text] [Related]
24. Screening of Target Genes and Regulatory Function of miRNAs as Prognostic Indicators for Prostate Cancer.
Xiaoli Z; Yawei W; Lianna L; Haifeng L; Hui Z
Med Sci Monit; 2015 Dec; 21():3748-59. PubMed ID: 26628405
[TBL] [Abstract][Full Text] [Related]
25. Down-regulation of miR-26a-5p in hepatocellular carcinoma: A qRT-PCR and bioinformatics study.
Liang L; Zeng JH; Wang JY; He RQ; Ma J; Chen G; Cai XY; Hu XH
Pathol Res Pract; 2017 Dec; 213(12):1494-1509. PubMed ID: 29113686
[TBL] [Abstract][Full Text] [Related]
26. Identification of key DNA methylation-driven genes in prostate adenocarcinoma: an integrative analysis of TCGA methylation data.
Xu N; Wu YP; Ke ZB; Liang YC; Cai H; Su WT; Tao X; Chen SH; Zheng QS; Wei Y; Xue XY
J Transl Med; 2019 Sep; 17(1):311. PubMed ID: 31533842
[TBL] [Abstract][Full Text] [Related]
27. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
Gene; 2019 May; 698():9-18. PubMed ID: 30825595
[TBL] [Abstract][Full Text] [Related]
28. Potential value of MicroRNA-21 as a biomarker for predicting the prognosis of patients with breast cancer: A protocol for meta-analysis and bioinformatics analysis.
Ding Y; Wu W; Ma Z; Shao X; Zhang M; Wang Z
Medicine (Baltimore); 2021 Jun; 100(22):e25964. PubMed ID: 34087839
[TBL] [Abstract][Full Text] [Related]
29. Identification and Interaction Analysis of Molecular Markers in Colorectal Cancer by Integrated Bioinformatics Analysis.
Han B; Feng D; Yu X; Zhang Y; Liu Y; Zhou L
Med Sci Monit; 2018 Aug; 24():6059-6069. PubMed ID: 30168505
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of miR‑224‑5p in prostate cancer and its relevant molecular mechanism via TCGA, GEO database and in silico analyses.
Gan BL; Zhang LJ; Gao L; Ma FC; He RQ; Chen G; Ma J; Zhong JC; Hu XH
Oncol Rep; 2018 Dec; 40(6):3171-3188. PubMed ID: 30542718
[TBL] [Abstract][Full Text] [Related]
31. The biological functions of target genes in pan-cancers and cell lines were predicted by miR-375 microarray data from GEO database and bioinformatics.
Zeng JH; Liang XZ; Lan HH; Zhu X; Liang XY
PLoS One; 2018; 13(10):e0206689. PubMed ID: 30379973
[TBL] [Abstract][Full Text] [Related]
32. The role of upregulated miR-375 expression in breast cancer: An in vitro and in silico study.
Tang W; Li GS; Li JD; Pan WY; Shi Q; Xiong DD; Mo CH; Zeng JJ; Chen G; Feng ZB; Huang SN; Rong MH
Pathol Res Pract; 2020 Jan; 216(1):152754. PubMed ID: 31787478
[TBL] [Abstract][Full Text] [Related]
33. miRNA expression patterns in chemoresistant breast cancer tissues.
Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
[TBL] [Abstract][Full Text] [Related]
34. Pathway crosstalk analysis in prostate cancer based on protein-protein network data.
Li HY; Jin N; Han YP; Jin XF
Neoplasma; 2017; 64(1):22-31. PubMed ID: 27881001
[TBL] [Abstract][Full Text] [Related]
35. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis.
Mou T; Zhu D; Wei X; Li T; Zheng D; Pu J; Guo Z; Wu Z
World J Surg Oncol; 2017 Mar; 15(1):63. PubMed ID: 28302149
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis.
Gan BL; He RQ; Zhang Y; Wei DM; Hu XH; Chen G
Int J Oncol; 2018 Oct; 53(4):1557-1579. PubMed ID: 30066858
[TBL] [Abstract][Full Text] [Related]
37. In silico identification of key genes and signaling pathways targeted by a panel of signature microRNAs in prostate cancer.
Baruah MM; Sharma N
Med Oncol; 2019 Apr; 36(5):43. PubMed ID: 30937635
[TBL] [Abstract][Full Text] [Related]
38. Identifying
Liu XT; Liu TT; Wu MY; Chen QX; Zhuang JX; Wang Q
Genet Test Mol Biomarkers; 2021 Jan; 25(1):68-78. PubMed ID: 33470885
[No Abstract] [Full Text] [Related]
39. Potential Targets and Clinical Value of MiR-224-5p in Cancers of the Digestive Tract.
Zhang L; Huang LS; Chen G; Feng ZB
Cell Physiol Biochem; 2017; 44(2):682-700. PubMed ID: 29169158
[TBL] [Abstract][Full Text] [Related]
40. Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach.
Fang E; Zhang X; Wang Q; Wang D
Cancer Biomark; 2017 Dec; 20(4):553-561. PubMed ID: 28800317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
